ACT 2 Logo
TREATMENT · ESTRADIOL CREAM · TREND

Estrogen Face Cream: What Topical Estradiol Does and Doesn't Do for Skin

Somewhere in 2025 "estrogen face cream" went from a dermatology footnote to a search term, and by 2026 it was being sold — as compounded estriol creams for the face, as off-label use of systemic estradiol gel, and as a claim in skincare marketing that stops just short of naming a hormone. The biology behind it is real. The evidence under it is thinner than the trend suggests, and the safety question is not the one most of the coverage asks.

This page is the honest version, written from the perspective of a practice that prescribes estradiol cream for the whole body and gets asked, weekly, whether it can go on the face.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

What estrogen does to skin

Skin has estrogen receptors, and estrogen matters to it. It drives collagen production, maintains the skin's water content, supports the fat layer beneath it and the blood supply within it. The first five years after menopause see a loss of roughly a third of skin collagen — a faster decline than at any other point in adult life — followed by a slower, steady loss thereafter. Thinning, dryness, loss of elasticity and deeper wrinkling follow, and they follow estrogen loss rather than age alone: a woman in surgical menopause at 42 sees the change at 42.

Systemic hormone therapy blunts this. Women on estradiol for menopausal symptoms have measurably thicker skin, more collagen and better hydration than untreated women of the same age — a side benefit of a treatment given for other reasons, and a reasonable one to mention in a conversation about starting it.

What the studies show for creams on the face

Less than the trend implies, and the details matter.

A 2025 systematic review in the Journal of the American Academy of Dermatology gathered the trials of topical estrogen for skin aging. The consistent finding: applied to skin, estrogen preparations increase collagen, thickness and hydration at the site of application, with improvements in fine wrinkling in several studies.

The caveats are the substance of the page. Most of the trials were small, short and decades old. Many used estriol rather than estradiol, at strengths chosen by the investigators. Several measured absorption and found it — topical estrogen on the face is not confined to the face. And none was designed to answer the question that matters for a woman with a uterus: whether facial application, over years, delivers enough systemic estrogen to stimulate the uterine lining without the progesterone that would protect it.

That is the safety question. It is not "is estrogen bad for skin" — it is good for skin — but "is an unmonitored systemic hormone, applied for cosmetic reasons, without the protections that go with systemic therapy, a good idea." We do not think it is.

What we will and will not prescribe

We prescribe estradiol as systemic hormone therapy, for menopausal symptoms and for the long-term benefits — bone, and likely cardiovascular within the timing window — that go with it. Better skin is a real side benefit of that treatment, and a woman on the patch or gel for the right reasons is entitled to enjoy it.

We do not prescribe estradiol or estriol cream for the face, as a cosmetic, in a woman who does not otherwise need hormone therapy. The reasons are the ones above: the exposure is systemic, the amount is uncontrolled, the uterine protection is absent, and the evidence base is small studies of a different question. It is the same reasoning as the vaginal-versus-systemic page in reverse — a product being used at a site it was not designed for, with consequences the user has not been told about.

A woman on systemic estradiol who wants to know whether she may apply her gel to her face should ask her clinician rather than assume; the answer depends on the product and the plan, and it is a conversation, not a rule.

What actually helps skin at menopause

The unglamorous list, in order of evidence: daily broad-spectrum sunscreen, which outperforms every hormone for photoageing; a topical retinoid, which has decades of controlled data for collagen and wrinkling; moisturizers that restore barrier function; and — for the woman who qualifies for it on other grounds — systemic hormone therapy, which treats the underlying loss. A dermatologist adds the procedures. None of that requires putting a systemic hormone on your cheeks.

Questions

Frequently asked questions

  • Applied to skin, estrogen increases collagen, thickness and hydration in small trials. Systemic hormone therapy has the same effect body-wide. The question is not whether it works but whether using a systemic hormone as a cosmetic is wise.

  • We do not prescribe it for that purpose. Facial application delivers estrogen systemically, in an uncontrolled amount, without the uterine protection systemic therapy requires. A woman already on systemic estradiol should ask her clinician rather than assume.

  • A compounded cream using estriol, a weaker estrogen, marketed for facial skin. It is still a hormone, it is still absorbed, and the trials behind it are small and old.

  • Yes — women on systemic estradiol have thicker, better-hydrated skin with more collagen than untreated women of the same age. It is a side benefit, not a reason on its own.

  • Topical retinoids have far more controlled evidence for photoageing and wrinkling, and no hormonal effect. Sunscreen outperforms both.

  • Products that avoid naming a hormone are avoiding it for regulatory reasons. Anything that contains estrogen is a drug, and anything that does not cannot do what estrogen does.

Your next step

Where this fits in your plan

The Estradiol Cream page covers the product as it is meant to be used. If menopausal symptoms are part of the picture, the women's HRT page is where the skin benefit comes as part of a plan rather than as a cosmetic.

We measure first. Then we act.

References

  1. Topical estrogen for skin aging: a systematic review of safety and efficacy. Journal of the American Academy of Dermatology 2025.
  2. Brincat M et al. Long-term effects of the menopause and sex hormones on skin thickness. British Journal of Obstetrics and Gynecology 1985;92:256–259.
  3. Schmidt JB et al. Treatment of skin aging with topical estrogens. International Journal of Dermatology 1996;35:669–674.
  4. Thornton MJ. Estrogens and aging skin. Dermato-Endocrinology 2013;5:264–270.
  5. Rzepecki AK et al. Estrogen-deficient skin: the role of topical therapy. International Journal of Women's Dermatology 2019;5:85–90.
  6. Mukherjee S et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clinical Interventions in Aging 2006;1:327–348.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

We measure first. Then we act.

Start with a baseline. Then decide about estradiol cream.